Terms: = Uterine cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
12 results:
1. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract] [Full Text] [Related]
2. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Wu Y; Huang J; Ivan C; Sun Y; Ma S; Mangala LS; Fellman BM; Urbauer DL; Jennings NB; Ram P; Coleman RL; Hu W; Sood AK
Gynecol Oncol; 2021 Oct; 163(1):181-190. PubMed ID: 34391578
[TBL] [Abstract] [Full Text] [Related]
3. ABCC4/MRP4 contributes to the aggressiveness of myc-associated epithelial ovarian cancer.
Jung M; Gao J; Cheung L; Bongers A; Somers K; Clifton M; Ramsay EE; Russell AJ; Valli E; Gifford AJ; George J; Kennedy CJ; Wakefield MJ; Topp M; Ho GY; ; Scott CL; Bowtell DD; deFazio A; Norris MD; Haber M; Henderson MJ
Int J Cancer; 2020 Oct; 147(8):2225-2238. PubMed ID: 32277480
[TBL] [Abstract] [Full Text] [Related]
4. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract] [Full Text] [Related]
5. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract] [Full Text] [Related]
6. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
[TBL] [Abstract] [Full Text] [Related]
7. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of outcome in small cell carcinoma of the cervix--a case series.
Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
[TBL] [Abstract] [Full Text] [Related]
9. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract] [Full Text] [Related]
10. New directions for radiation biology research in cancer of the uterine cervix.
Kapp DS; Giaccia AJ
J Natl Cancer Inst Monogr; 1996; (21):131-9. PubMed ID: 9023843
[TBL] [Abstract] [Full Text] [Related]
11. Endometrial cancer: biochemical and clinical correlates.
Gurpide E
J Natl Cancer Inst; 1991 Mar; 83(6):405-16. PubMed ID: 1999848
[TBL] [Abstract] [Full Text] [Related]
12. c-myc oncogene expression and clinical outcome in carcinoma of the cervix.
Sowani A; Ong G; Dische S; Quinn C; White J; Soutter P; Waxman J; Sikora K
Mol Cell Probes; 1989 Jun; 3(2):117-23. PubMed ID: 2671679
[TBL] [Abstract] [Full Text] [Related]